Pharmaceutical Editorial
  • Home
  • News
  • About
  • Contact

Introducing the New Kid on the Block to Treat Depression: “Brintellix”

Physician Commentary, Psych Drugs

Introducing the New Kid on the Block to Treat Depression: “Brintellix”.

October 1, 2013-Takeda Pharmaceuticals has just released their latest FDA-approved medication to treat adults with Major Depressive Disorder called “Brintellix” with the generic name of “Vorioxetine”. It is available in 5mg, 10mg, and 20mg tablets. It works on Serotonin receptors, which means that it is a cousin of antidepressants such as Paxil, Prozac, Celexa, Lexapro, and Viibryd.

By Dr. Terra Caudill

Related Posts

Medical, Pharmaceutical, Pharmaceuticals, Press Releases

Flexion to Present New Cost-Effectiveness Data on Zilretta™ (FX006) at the International Society for Pharmacoeconomics and Outcomes Research 22nd International Meeting

Allergan, Medical, Pharmaceutical, Pharmaceuticals, Press Releases

Allergan’s Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications

Medical, Pharmaceutical, Pharmaceuticals, Press Releases

The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures

Featured News

  • Flexion to Present New Cost-Effectiveness Data on Zilretta™ (FX006) at the International Society for Pharmacoeconomics and Outcomes Research 22nd International Meeting
  • Allergan’s Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications
  • The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures
  • Abbott Announces CE Mark for Tacticath™ Contact Force Ablation Catheter, Sensor Enabled™
  • Abbott Announces CE Mark and First Use of the World’s First SmartPhone Compatible Insertable Cardiac Monitor
Pharmaceutical Editorial
Copyright © PhysicianEditorial.com
All Rights Reserved!